ADMA Biologics, Inc.
ADMA Biologics, Inc. (ADMA) Revenue
Annual & quarterly revenue history · segment & region breakdown
ADMA · revenue · updated Jun 8, 2026
Core revenue metrics
Trailing 12 monthsADMA Biologics, Inc. trailing twelve-month (TTM) revenue is $0.51B, an increase of 19.63% year-over-year from $0.51B in FY2025.
Revenue trend
2025 – 2007 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-12-31 | $0.51B | +$0.08B | +19.63% |
| 2024-12-31 | $0.43B | +$0.17B | +65.15% |
| 2023-12-31 | $0.26B | +$0.10B | +67.59% |
| 2022-12-31 | $0.15B | +$0.07B | +90.36% |
| 2021-12-31 | $0.08B | +$0.04B | +91.72% |
| 2020-12-31 | $0.04B | +$0.01B | +43.85% |
| 2019-12-31 | $0.03B | +$0.01B | +72.79% |
| 2018-12-31 | $0.02B | -$0.01B | -25.37% |
| 2017-12-31 | $0.02B | +$0.01B | +113.49% |
| 2016-12-31 | $0.01B | +$0.00B | +48.53% |
Compare revenue vs peers
BiotechnologyCompare ADMA revenue against listed peers. Click any row to open that company's revenue tab.
Revenue breakdown
Segment & GeographyAbout Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income ADMA Biologics, Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
ADMA Biologics, Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from ADMA Biologics, Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
ADMA revenue · 4 questionsADMA's trailing twelve-month (TTM) revenue is $0.51B. That is an increase of 19.63% year-over-year from $0.51B in FY2025.
▸ Source: FMP · ADMA Biologics, Inc. SEC filings · GAAP · ADMA Biologics, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026